|
Market Closed -
Nasdaq
01:30:00 25/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 146.74 USD | +0.42% |
|
+5.63% | +19.55% |
| 09:30am | Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US | MT |
| 25/08 | Lakefront Gets FDA Orphan Drug Label for Gamgertamig | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +0.42% | +5.63% | +19.55% | +27.86% | +103.10% | 18TCr |  |  | |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
